Nolato AB (NOLA.B) AI Stock Analysis

• Market Cap: $15.56B
• Dividend Yield: 2.6%
• Average Volume (3M): 169.66K
• Price to Earnings (P/E): 22.4
• Beta (1Y): 1.06
• Revenue Growth: 1.71%
• EPS Growth: 50.75%
• Country: SE
• Employees: 5,405
• Sector: Industrials
• Sector Strength: 93
• Industry: Conglomerates
• EPS (TTM): 0.70
• Shares Outstanding: 241,783,080
• 10 Day Avg. Volume: 123,462
• 30 Day Avg. Volume: 169,663
• PEG Ratio: 3.92
• Price to Book (P/B): 2.80
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 11.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 77 Outperform
• Price Target: kr66.00 ▲(13.30%Upside)

Nolato AB's overall stock score reflects its strong financial performance, characterized by significant revenue growth and a debt-free balance sheet, which indicates financial stability and operational efficiency. The technical analysis shows positive momentum but hints at potential caution due to overbought signals. While the valuation suggests some concerns about overvaluation, the company's robust financial health and positive technical indicators support a solid overall score.

Nolato AB Business Overview & Revenue Model

Company Description

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.

How the Company Makes Money

Nolato AB generates revenue primarily through the design, development, and manufacture of polymer-based product systems. The company operates through three main business segments: Medical Solutions, Integrated Solutions, and Industrial Solutions. In the Medical Solutions segment, Nolato provides polymer products and product systems for medical devices and pharmaceuticals, generating revenue through long-term partnerships with healthcare companies. The Integrated Solutions segment focuses on the consumer electronics industry, where Nolato designs and manufactures components and systems for consumer products, leveraging its expertise in miniaturization and precision engineering. The Industrial Solutions segment caters to the automotive and general industry sectors, providing a wide range of polymer products and systems. Nolato's revenue is driven by a combination of direct sales to these industries, as well as strategic partnerships and collaborations that expand its market reach and enhance its product offerings.

Nolato AB Financial Statement Overview

Summary

Nolato AB exhibits robust financial health across income, balance sheet, and cash flow metrics. The company has achieved strong revenue and profit growth, maintained a solid balance sheet with no debt, and generated significant free cash flow. These factors collectively reflect efficient operations, reduced financial risk, and potential for sustained growth. The company's financial stability and operational efficiency position it well for the future.

Income Statement

Nolato AB has shown impressive revenue growth from 2023 to 2024, with a positive trajectory in gross profit and net income, reflecting strong operational performance. The gross profit margin improved to 16.69%, and the net profit margin increased to 6.81%, indicating enhanced profitability. EBIT and EBITDA margins also indicate robust operating efficiency. Overall, the company demonstrates solid revenue growth and profitability metrics, with room for further margin improvements.

Balance Sheet

The balance sheet of Nolato AB is strong, with a debt-free position contributing to stability. The equity ratio is high at 59.23%, indicating significant financial stability and low leverage risk. Return on equity has improved to 11.47%, showcasing efficient use of shareholder capital. The company has effectively managed its liabilities, reducing total debt to zero, thus minimizing financial risk.

Cash Flow

Cash flow analysis reveals excellent performance with significant free cash flow growth and strong operating cash flow. The free cash flow growth rate was substantial, and the operating cash flow to net income ratio of 2.09 indicates excellent cash generation relative to net income. The company's ability to generate free cash flow supports future investment opportunities and financial flexibility.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.68B	9.66B	9.55B	10.77B	11.61B	9.36B
Gross Profit	1.66B	1.61B	1.34B	1.43B	1.82B	1.51B
EBITDA	1.40B	1.52B	1.28B	1.48B	1.92B	1.46B
Net Income	695.00M	658.00M	435.00M	697.00M	1.16B	806.00M
Balance Sheet
Total Assets	9.41B	9.69B	9.30B	10.01B	10.05B	8.68B
Cash, Cash Equivalents and Short-Term Investments	568.00M	672.00M	688.00M	1.01B	1.45B	1.49B
Total Debt	0.00	1.53B	1.88B	1.93B	1.62B	1.88B
Total Liabilities	3.85B	3.95B	4.13B	4.62B	5.29B	4.99B
Stockholders Equity	5.56B	5.74B	5.17B	5.39B	4.77B	3.70B
Cash Flow
Free Cash Flow	1.38B	737.00M	351.00M	-49.00M	446.00M	791.00M
Operating Cash Flow	1.38B	1.38B	781.00M	406.00M	1.23B	1.16B
Investing Cash Flow	-677.00M	-636.00M	-444.00M	-451.00M	-782.00M	-1.70B
Financing Cash Flow	-764.00M	-798.00M	-631.00M	-487.00M	-634.00M	730.00M

Nolato AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 58.25
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOLA.B, the sentiment is Positive. The current price of 58.25 is above the 20-day moving average (MA) of 57.71, above the 50-day MA of 57.84, and above the 200-day MA of 55.15, indicating a bullish trend. The MACD of 0.23 indicates Positive momentum. The RSI at 52.79 is Neutral, neither overbought nor oversold. The STOCH value of 45.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NOLA.B.

Nolato AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NOLA.B	77 Outperform	$15.56B	22.38	12.19%	2.60%	1.71%	50.75%
Sector *	65 Neutral	$10.90B	15.41	5.26%	1.89%	3.11%	-26.85%
7AQ0	―	€1.50B	26.16	15.38%	0.86%	―	―
52SA	―	€1.71B	28.77	11.86%	1.30%	―	―
2GP	―	€1.48B	24.66	9.04%	1.93%	―	―
29B0	―	€1.59B	29.40	15.89%	53.89%	―	―
BRAV	74 Outperform	kr19.42B	17.44		4.11%	-3.75%	1.20%

Nolato AB Corporate Events

Nolato AB to Release Q2 2025 Interim Report and Host Webcast

Nolato AB announced it will release its interim report for the second quarter of 2025 on July 18, followed by a webcast conference call. This event will feature presentations by the company’s President and CEO, Christer Wahlquist, and CFO, Per-Ola Holmström, providing insights into the company’s performance and addressing questions from stakeholders.

Nolato AB Approves Key Resolutions at Annual General Meeting

Nolato AB held its Annual General Meeting on May 6, 2025, where all proposals by the Board and Nomination Committee were approved. Key resolutions included the re-election of board members, the appointment of Klas Forsström as the new Chairman, and the approval of a dividend payment. Additionally, an incentive program involving the issuance of warrants for senior executives was introduced, and the Board was authorized to issue new class B shares until the next AGM. These decisions are expected to enhance Nolato’s governance and incentivize leadership, potentially impacting its strategic growth and market positioning.

Nolato AB Reports Strong Q1 2025 Financial Performance with Increased EBITA Margin

Nolato AB reported a strong financial performance in the first quarter of 2025, with an increase in operating profit and a substantial rise in EBITA margin to 11.0%. The company achieved this through strategic price and cost adjustments, as well as a favorable product mix, particularly in the Medical Solutions and Materials segments. Despite a slight decrease in net sales adjusted for currency, Nolato’s strategic focus on innovation and sustainability has led to winning significant customer contracts, positioning the company for continued profitable growth. The company remains resilient amid global trade uncertainties, leveraging its global production capacity to support customers and maintain a strong financial position.